BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37165926)

  • 21. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
    Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
    Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report.
    Ishikawa Y; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Jingu K
    J Med Case Rep; 2022 Mar; 16(1):94. PubMed ID: 35248152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
    Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
    J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
    Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma.
    Sun D; Liu D; Liu Q; Hou H
    Cancer Biol Ther; 2020 Dec; 21(12):1097-1104. PubMed ID: 33151119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.
    Zhang W; Yan C; Gao X; Li X; Cao F; Zhao G; Zhao J; Er P; Zhang T; Chen X; Wang Y; Jiang Y; Wang Q; Zhang B; Qian D; Wang J; Zhou D; Ren X; Yu Z; Zhao L; Yuan Z; Wang P; Pang Q
    Oncologist; 2021 Jul; 26(7):e1110-e1124. PubMed ID: 33893689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy-induced abscopal effect on the metastatic carcinoma of unknown primary origin: a case report and literature review.
    Guo Z; Zhou J; Guo H; Liu LK
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4634-4637. PubMed ID: 35856353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
    Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
    World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Treatment of Advanced Gastric Cancer with Brain Metastases through an Abscopal Effect by Radiation and Immune Checkpoint Inhibitor Therapy.
    Muto M; Nakata H; Ishigaki K; Tachibana S; Yoshida M; Muto M; Yanagawa N; Okumura T
    J Gastric Cancer; 2021 Sep; 21(3):319-324. PubMed ID: 34691815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
    Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
    Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report.
    Fiorica F; Belluomini L; Giuliani J; Urbini B; Milella M; Frassoldati A; Pilotto S; Giorgi C
    Immunotherapy; 2021 Aug; 13(12):971-976. PubMed ID: 34180714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
    Wu X; Hu X; Chen J; He L
    Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.
    Kato K; Cho BC; Takahashi M; Okada M; Lin CY; Chin K; Kadowaki S; Ahn MJ; Hamamoto Y; Doki Y; Yen CC; Kubota Y; Kim SB; Hsu CH; Holtved E; Xynos I; Kodani M; Kitagawa Y
    Lancet Oncol; 2019 Nov; 20(11):1506-1517. PubMed ID: 31582355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dramatic response to nivolumab after local radiotherapy in pulmonary pleomorphic carcinoma with rapid progressive post-surgical recurrence.
    Yaguchi D; Ichikawa M; Ito M; Okamoto S; Kimura H; Watanabe K
    Thorac Cancer; 2019 May; 10(5):1263-1266. PubMed ID: 30860657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition.
    Yu J; Ouyang W; Li C; Shen J; Xu Y; Zhang J; Xie C
    BMC Cancer; 2019 Sep; 19(1):927. PubMed ID: 31533656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma.
    McBride S; Sherman E; Tsai CJ; Baxi S; Aghalar J; Eng J; Zhi WI; McFarland D; Michel LS; Young R; Lefkowitz R; Spielsinger D; Zhang Z; Flynn J; Dunn L; Ho A; Riaz N; Pfister D; Lee N
    J Clin Oncol; 2021 Jan; 39(1):30-37. PubMed ID: 32822275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pattern of relapse following three-field lymphadenectomy of esophageal carcinoma and related factors predictive of recurrence.
    Xu ZC; Su BA; Li JC; Cheng WF; Chen J
    Cancer Radiother; 2023 May; 27(3):189-195. PubMed ID: 36754752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.